EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigation of Thiazolidine‐2,4‐Dione Derivatives as Acetylcholinesterase Inhibitors: Synthesis, In Vitro Biological Activities and In Silico Studies

Hanane Naeimi iD, Maryam Taheri iD, Hossein Ghafouri iD, Asadollah Mohammadi iD

ChemistryOpen · 2025

DOI: 10.1002/open.202400294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistryOpen, 2025. Verfasst von Hanane Naeimi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Basic Sciences, University of Guilan, Rasht, 4193833697, Iran. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Acetylcholinesterase, Thiazolidinediones. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The inhibition of acetylcholinesterase (AChE), an enzyme responsible for the inactivation and decrease in acetylcholine in the cholinergic pathway, has been considered an attractive target for small‐molecule drug discovery in Alzheimer's disease (AD) therapy. In the present study, a series of TZD derivatives were designed, synthesized, and studied for drug likeness, blood–brain barrier (BBB) permeability, and adsorption, distribution, metabolism, excretion, and toxicity (ADMET). Additionally, docking studies of the designed compounds were performed on AChE. Additionally, all the TZD derivatives (CHT1‐5) showed an acceptable affinity for AChE inhibition, and the results showed convincing binding modes in the active site of AChE. Among them, 5‐(4‐methoxybenzylidene) thiazolidine‐2,4‐dione (CHT1) was identified as the most potent AChE inhibitor (IC 50 of 165.93 nM) with the highest antioxidant activity. Following the exposure of PC12 cells to Aβ1‐42 (100 μM), a marked reduction in cell survival was observed. Pretreatment of PC12 cells with TZD derivatives had a neuroprotective effect and significantly enhanced cell survival in response to Aβ‐induced toxicity. Western blotting analysis revealed that CHT1 (5 and 8 μM) downregulated p‐Tau and HSP70 expression levels. The results indicate that CHT1 is a promising and effective AchE‐I that could be utilized as a powerful candidate against AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsAcetylcholinesteraseThiazolidinedionesPC12 CellsRatsAnimalsMolecular Docking SimulationAmyloid beta-PeptidesAntioxidantsStructure-Activity RelationshipBlood-Brain BarrierNeuroprotective AgentsCell Survival

Stichwörter der Autor:innen

Acetylcholinesterase (AChE)Alzheimer's disease (AD)Biological activityInhibitorsThiazolidine-2,4-dione (TZD)

Substanzen

Cholinesterase InhibitorsAcetylcholinesterasethiazolidine-2,4-dioneThiazolidinedionesAmyloid beta-PeptidesAntioxidantsNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Biology, Faculty of Basic Sciences, University of Guilan, Rasht, 4193833697, Iran.
  • Department of Chemistry, Faculty of Sciences, University of Guilan, Rasht, 4193833697, Iran.

ORCID-Profile: Hanane Naeimi, Maryam Taheri, Hossein Ghafouri, Asadollah Mohammadi

Zitieren

APA

Naeimi, H., Taheri, M., Ghafouri, H., & Mohammadi, A. (2025). Investigation of Thiazolidine‐2,4‐Dione Derivatives as Acetylcholinesterase Inhibitors: Synthesis, In Vitro Biological Activities and In Silico Studies. ChemistryOpen. https://doi.org/10.1002/open.202400294

Vancouver

Naeimi H, Taheri M, Ghafouri H, Mohammadi A. Investigation of Thiazolidine‐2,4‐Dione Derivatives as Acetylcholinesterase Inhibitors: Synthesis, In Vitro Biological Activities and In Silico Studies. ChemistryOpen. 2025. doi:10.1002/open.202400294

BibTeX
@article{Naeimi2025,
  author = {Naeimi, Hanane and Taheri, Maryam and Ghafouri, Hossein and Mohammadi, Asadollah},
  title = {Investigation of Thiazolidine‐2,4‐Dione Derivatives as Acetylcholinesterase Inhibitors: Synthesis, In Vitro Biological Activities and In Silico Studies},
  journal = {ChemistryOpen},
  year = {2025},
  doi = {10.1002/open.202400294}
}
Kostenlos starten →